MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis

FASEB Journal

Volumn 29, Issue 11, 2015, Pages 4497-4511

  Alampour Rajabi, Setareh ^a   El Bounkari, Omar ^a   Rot, Antal ^b   Müller Newen, Gerhard ^a   Bachelerie, Françoise ^c   Gawaz, Meinrad ^d   Weber, Christian ^e,f,h   Schober, Andreas ^e   Bernhagen, Jürgen ^a,f,g  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF YORK   (United Kingdom)

^c INSERM   (France)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

CD74; Chemokine; Chemokine receptor; Cytokine; Receptor complex

Indexed keywords

CD74 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE ZAP 70; CHEMOKINE RECEPTOR CXCR; CMKOR1 PROTEIN, MOUSE; CXCL12 PROTEIN, HUMAN; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, HUMAN; CXCR4 PROTEIN, MOUSE; CXCR7 PROTEIN, HUMAN; ISOMERASE; MAPK1 PROTEIN, HUMAN; MIF PROTEIN, HUMAN; MIF PROTEIN, MOUSE; STROMAL CELL DERIVED FACTOR 1; ZAP70 PROTEIN, HUMAN; ZAP70 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CHEMOKINE CXCL12; CHEMOTAXIS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTORS, CXCR; RECEPTORS, CXCR4; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84949023960     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-273904     Document Type: Article

References (68)

1. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759
2. Calandra, T., and Roger, T. (2003) Macrophagemigrationinhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800
3. Morand, E. F., Leech, M., and Bernhagen, J. (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399-410
4. Tillmann, S., Bernhagen, J., and Noels, H. (2013) Arrest functions of theMIF ligand/receptor axes inatherogenesis. Front. Immunol. 4, 115
5. Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., and Shachar, I. (2008) Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283, 2784-2792
6. Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A., and Shachar, I. (2006) Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107, 4807-4816
7. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., Noble, P., Knudson, W., and Bucala, R. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606
8. Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., and Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476
9. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596
10. Weber, C., Kraemer, S., Drechsler, M., Lue, H., Koenen, R. R., Kapurniotu, A., Zernecke, A., and Bernhagen, J. (2008) Structural determinants of MIF functions in CXCR2-mediated inflammatory andatherogenic leukocyterecruitment. Proc.Natl.Acad. Sci.USA105, 16278-16283
11. Kraemer, S., Lue, H., Zernecke, A., Kapurniotu, A., Andreetto, E., Frank, R., Lennartz, B., Weber, C., and Bernhagen, J. (2011) MIF-chemokine receptor interactions in atherogenesis are dependent on anN-loopbased 2-site binding mechanism. FASEB J. 25, 894-906
12. Schwartz, V., Lue, H., Kraemer, S., Korbiel, J., Krohn, R., Ohl, K., Bucala, R., Weber, C., and Bernhagen, J. (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 583, 2749-2757
13. Lue, H., Dewor, M., Leng, L., Bucala, R., and Bernhagen, J. (2011) Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell. Signal. 23, 135-144
14. Klasen, C., Ohl, K., Sternkopf, M., Shachar, I., Schmitz, C., Heussen, N., Hobeika, E., Levit-Zerdoun, E., Tenbrock, K., Reth, M., Bernhagen, J., and El Bounkari, O. (2014) MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J. Immunol. 192, 5273-5284
15. Ulvmar, M. H., Hub, E., and Rot, A. (2011) Atypical chemokine receptors. Exp. Cell Res. 317, 556-568
16. Burns, J.M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., and Schall, T. J. (2006)A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213
17. Infantino, S., Moepps, B., and Thelen, M. (2006) Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J. Immunol. 176, 2197-2207
18. Law, N.M., and Rosenzweig, S. A. (1994) Characterization of the GproteinlinkedorphanreceptorGPRN1/ RDC1.Biochem.Biophys.Res. Commun. 201, 458-465
19. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., and Bachelerie, F. (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280, 35760-35766
20. Fredriksson, R., Lagerström, M. C., Lundin, L. G., andSchiöth, H. B. (2003) The G-protein-coupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272
21. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., and Lefkowitz, R. J. (2010) Beta-arrestin-but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. USA 107, 628-632
22. Ray, P., Mihalko, L.A., Coggins, N.L., Moudgil, P., Ehrlich, A., Luker, K. E., and Luker, G.D. (2012)Carboxy-terminus ofCXCR7 regulates receptor localization and function. Int. J. Biochem. Cell Biol. 44, 669-678
23. Luker, K.E., Gupta, M., andLuker, G. D. (2009)Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J. 23, 823-834
24. Sánchez-Alcañiz, J. A., Haege, S., Mueller, W., Pla, R., Mackay, F., Schulz, S., López-Bendito, G., Stumm, R., and Marín, O. (2011) Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69, 77-90
25. Zabel, B. A., Wang, Y., Lewén, S., Berahovich, R.D., Penfold, M. E., Zhang, P., Powers, J., Summers, B. C., Miao, Z., Zhao, B., Jalili, A., Janowska-Wieczorek, A., Jaen, J. C., and Schall, T. J. (2009) Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 183, 3204-3211
26. Yan, X., Cai, S., Xiong, X., Sun, W., Dai, X., Chen, S., Ye, Q., Song, Z., Jiang, Q., and Xu, Z. (2012) Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation. J. Cell. Biochem. 113, 1437-1446
27. Kraemer, S., Alampour-Rajabi, S., ElBounkari, O., andBernhagen, J. (2013) Hetero-oligomerization of chemokine receptors: diversity and relevance for function. Curr. Med. Chem. 20, 2524-2536
28. Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., and Sachdev, P. (2011) CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J. Biol. Chem. 286, 32188-32197
29. Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., and Lagane, B. (2009) CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113, 6085-6093
30. Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R.M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., Harvey, R. P., Martínez-A, C., Mackay, C.R., andMackay, F. (2007)Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104, 14759-14764
31. Chatterjee, M., and Gawaz, M. (2013) Platelet-derived CXCL12 (SDF-1a): basic mechanisms and clinical implications. J. Thromb. Haemost. 11, 1954-1967
32. Rath, D., Chatterjee, M., Borst, O., Müller, K., Stellos, K., Mack, A. F., Bongartz, A., Bigalke, B., Langer, H., Schwab, M., Gawaz, M., and Geisler, T. (2014) Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery. Eur. Heart J. 35, 386-394
33. Chatterjee, M., Seizer, P., Borst, O., Schönberger, T., Mack, A., Geisler, T., Langer, H. F., May, A. E., Vogel, S., Lang, F., and Gawaz, M. (2014) SDF-1a induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival. FASEB J. 28, 2864-2878
34. Miao, Z., Luker, K. E., Summers, B.C., Berahovich, R., Bhojani, M. S., Rehemtulla, A., Kleer, C.G., Essner, J. J., Nasevicius, A., Luker, G. D., Howard, M. C., and Schall, T. J. (2007) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumorassociated vasculature. Proc. Natl. Acad. Sci. USA 104, 15735-15740
35. Zabel, B. A., Lewén, S., Berahovich, R.D., Jaén, J. C., and Schall, T. J. (2011) The novel chemokine receptor CXCR7 regulates transendothelial migration of cancer cells. Mol. Cancer 10, 73
36. Cruz-Orengo, L., Holman, D. W., Dorsey, D., Zhou, L., Zhang, P., Wright, M., McCandless, E. E., Patel, J. R., Luker, G. D., Littman, D. R., Russell, J. H., and Klein, R. S. (2011) CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208, 327-339
37. Watanabe, K., Penfold, M. E., Matsuda, A., Ohyanagi, N., Kaneko, K., Miyabe, Y., Matsumoto, K., Schall, T. J., Miyasaka, N., and Nanki, T. (2010) Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum. 62, 3211-3220
38. Li, X., Zhu, M., Penfold, M. E., Koenen, R. R., Thiemann, A., Heyll, K., Akhtar, S., Koyadan, S., Wu, Z., Gremse, F., Kiessling, F., van Zandvoort, M., Schall, T. J., Weber, C., and Schober, A. (2014) Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasingcholesteroluptake inadipose tissue. Circulation 129, 1244-1253
39. Tarnowski, M., Grymula, K., Liu, R., Tarnowska, J., Drukala, J., Ratajczak, J., Mitchell, R. A., Ratajczak, M. Z., and Kucia, M. (2010) Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol. Cancer Res. 8, 1328-1343
40. Chatterjee, M., Borst, O., Walker, B., Fotinos, A., Vogel, S., Seizer, P., Mack, A., Alampour-Rajabi, S., Rath, D., Geisler, T., Lang, F., Langer, H. F., Bernhagen, J., and Gawaz, M. (2014) Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. Circ. Res. 115, 939-949
41. Bernhagen, J., Mitchell, R. A., Calandra, T., Voelter, W., Cerami, A., and Bucala, R. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33, 14144-14155
42. Kleemann, R., Grell, M., Mischke, R., Zimmermann, G., and Bernhagen, J. (2002) Receptor binding and cellular uptake studies ofmacrophagemigration inhibitory factor (MIF): use of biologically active labeled MIF derivatives. J. Interferon Cytokine Res. 22, 351-363
43. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstr°ale, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and Landegren, U. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000
44. Costantini, S., Raucci, R., De Vero, T., Castello, G., and Colonna, G. (2013) Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach. Cytokine 64, 316-321
45. Humpert, M. L., Pinto, D., Jarrossay, D., and Thelen, M. (2014) CXCR7 influences themigration of B cells duringmaturation. Eur. J. Immunol. 44, 694-705
46. Borghese, F., and Clanchy, F. I. (2011) CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin. Ther. Targets 15, 237-251
47. Shachar, I., and Haran, M. (2011) The secret second life of an innocent chaperone: the story of CD74 and B cell/chronic lymphocytic leukemia cell survival. Leuk. Lymphoma 52, 1446-1454
48. Hattermann, K., and Mentlein, R. (2013) An infernal trio: the chemokine CXCL12 and its receptorsCXCR4 and CXCR7 in tumor biology. Ann. Anat. 195, 103-110
49. Sánchez-Martín, L., Sánchez-Mateos, P., and Cabañas, C. (2013) CXCR7 impact onCXCL12 biology and disease. Trends Mol.Med. 19, 12-22
50. Singh, A.K., Arya, R.K., Trivedi, A.K., Sanyal, S., Baral, R., Dormond, O., Briscoe, D. M., and Datta, D. (2013) Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev. 24, 41-49
51. Thelen, M., andThelen, S. (2008)CXCR7, CXCR4 andCXCL12: an eccentric trio? J. Neuroimmunol. 198, 9-13
52. Graham, G. J., Locati, M., Mantovani, A., Rot, A., and Thelen, M. (2012) The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145, 30-38
53. Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q., and Raz, E. (2008) Control of chemokine-guided cellmigrationby ligand sequestration. Cell 132, 463-473
54. Luker, K. E., Steele, J.M., Mihalko, L. A., Ray, P., and Luker, G.D. (2010) Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29, 4599-4610
55. Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.G., Rot, A., andThelen, M. (2010)CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5, e9175
56. Luker, K. E., Gupta, M., Steele, J.M., Foerster, B.R., and Luker, G. D. (2009) Imaging ligand-dependent activationofCXCR7.Neoplasia 11, 1022-1035
57. Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K. J., Mehra, R., Loberg, R., and Taichman, R. S. (2008) The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 283, 4283-4294
58. Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M.L., Parente, E., Mancina, R., Netti, G.S., Becherucci, F., Gacci, M., Carini, M., Gesualdo, L., Rotondi, M., Maggi, E., Lasagni, L., Serio, M., Romagnani, S., andRomagnani, P. (2008)Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 205, 479-490
59. Melo, RCC., Longhini, A. L., Bigarella, C. L., Baratti, M. O., Traina, F., Favaro, P., deMelo Campos, P., and Saad, S. T. (2014)CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLoS One 9, e85926
60. Dambly-Chaudière, C., Cubedo, N., and Ghysen, A. (2007) Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7, 23
61. Hartmann, T. N., Grabovsky, V., Pasvolsky, R., Shulman, Z., Buss, E. C., Spiegel, A., Nagler, A., Lapidot, T., Thelen, M., and Alon, R. (2008) A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 84, 1130-1140
62. Tarnowski, M., Liu, R., Wysoczynski, M., Ratajczak, J., Kucia, M., and Ratajczak, M. Z. (2010) CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. Eur. J. Haematol. 85, 472-483
63. Kumar, R., Tripathi, V., Ahmad, M., Nath, N., Mir, R. A., Chauhan, S. S., and Luthra, K. (2012) CXCR7 mediated Gia independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells. Cell. Immunol. 272, 230-241
64. Published correction (primer sequence error) in (2014) Cell. Immunol. 290:251.
65. Heinrich, E. L., Lee, W., Lu, J., Lowy, A. M., and Kim, J. (2012) Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J. Transl. Med. 10, 68
66. Lagane, B., Chow, K. Y., Balabanian, K., Levoye, A., Harriague, J., Planchenault, T., Baleux, F., Gunera-Saad, N., Arenzana-Seisdedos, F., and Bachelerie, F. (2008) CXCR4 dimerization and beta-arrestinmediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 112, 34-44
67. Wang, J., He, L., Combs, C. A., Roderiquez, G., and Norcross, M. A. (2006) Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol. Cancer Ther. 5, 2474-2483
68. Ding, B. S., Cao, Z., Lis, R., Nolan, D. J., Guo, P., Simons, M., Penfold, M. E., Shido, K., Rabbany, S. Y., and Rafii, S. (2014) Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 505, 97-102